Controlled Substances and Drug Diversion: Introduction 101
SKS Medication Safety Series, Chapter 12 of 15 · Standard SİY11
Prof. Dr. Mehmet Nurullah Kurutkan, Düzce Üniversitesi İşletme Fakültesi Sağlık Yönetimi Bölümü
Chapter at a glance
Narcotic and psychotropic medicines are essential for pain and sedation, but they carry risks of overdose, abuse and theft. This chapter covers safe handling of controlled substances in hospital: locked storage, custody and handover records, documentation discrepancies and diversion. It corresponds to SKS SİY11 (Sağlık Bakanlığı, 2020).
Evidence base: 115 records of a 4948-record Web of Science corpus on hospital medication safety (Section 7). Reading time: about 25 minutes. Prior knowledge required: none.
Learning objectives
After working through this chapter, the reader should be able to:
- state the SKS SİY11 requirements for narcotics and psychotropics;
- explain drug diversion and its contributors;
- describe documentation and handover risks;
- summarise interventions that reduce narcotic-related adverse events.
Key concepts
- Controlled substance: a medicine under legal control because of abuse potential
- Drug diversion: transfer of a drug from legitimate to illegitimate use
- Chain of custody (devir teslim): documented handover of controlled drugs
- Documentation discrepancy: mismatch between recorded and actual use or waste
- Patient-controlled analgesia (PCA): patient-triggered opioid delivery device
Contents: How this chapter was produced · 1. Introduction · 2. History and development · 3. Definitions and conceptual schema · 4. Distinguishing it from neighbouring concepts · 5. Types and classifications · 6. Theoretical frameworks and models · 7. Themes and bibliometric profile · 8. The situation in Türkiye · 9. Debates and contradictions in the literature · 10. Measurement problems · 11. Research gaps and agenda · 12. Implications for practice today · Summary · Discussion questions · Further reading · Glossary · References · Source verification and AI use statement · Data and supplementary material
How this chapter was produced
Box 1. Method
Database: Web of Science Core Collection (SCI-EXPANDED, SSCI, ESCI); English; articles and reviews (including early access). Search date: 16 November 2026; all years (1981 to 2027).
Search: (#1 medication safety and error terms AND #2 hospital settings AND #3 fifteen SKS content blocks) NOT #4 animal and preclinical terms; the full string is on the series hub.
Screening: five export files (4955 records) were merged; 7 duplicates were removed by WoS accession number, DOI and normalised title plus year, leaving 4948 records. Records were assigned to this sub-topic when its term set (controlled substance or drug, narcotic, diversion) appeared in the title or keywords or, for this thin sub-topic, the abstract; a record can belong to several sub-topics. Included here: 115 records (31 with the term in the title; 13 reviews).
Limitations: single database; English only; assignment by term matching, checked by reading titles of the most cited and most recent records; claims are checked against abstracts, not full texts.
4955 records
31 title matches; 13 reviews
other chapters or general records
1. Introduction
SKS requires that narcotic and psychotropic drugs be kept in locked areas, with defined exceptions and extra precautions; that handover be recorded with the patient, frequency and dose, date, who administered, to whom and how much was handed over, and signatures of both parties; that reports be written for narcotics damaged during storage or transport; and that narcotics destroyed because of expiry, spoilage or risk be recorded (Sağlık Bakanlığı, 2020).
The literature adds two concerns. Narcotic-related events are the most common adverse drug events in hospitalised children (Sharek et al., 2008), and drug losses and theft from the health care system are accelerating, putting pressure on hospitals to prevent diversion (Fan et al., 2019).
2. History and development
In 1992 a study asked whether narcotic use in hospital was reasonably safe (Whipple et al., 1992), and in 1994 the same group described a computerised method for identifying overdoses with patient-controlled analgesia (Whipple et al., 1994). Paediatric quality collaboratives targeted narcotic-related adverse events in 2008 (Sharek et al., 2008). The 2010s brought feedback interventions for prescribing errors (Sullivan et al., 2013) and quality improvement for documentation (Dolan et al., 2019). A 2019 scoping review organised the diversion literature (Fan et al., 2019), and a 2022 failure mode analysis described diversion vulnerabilities in hospital pharmacies (De Vries et al., 2022).
- 1992 Narcotic use in hospital assessed for safety (Whipple et al., 1992).
- 1994 Computerised identification of PCA overdoses in hospitalised patients (Whipple et al., 1994).
- 2008 14-hospital collaborative reduces narcotic-related ADEs in children (Sharek et al., 2008).
- 2013 Personalised feedback reduces narcotic prescribing errors in a NICU (Sullivan et al., 2013).
- 2019 Scoping review of diversion contributors and safeguards (Fan et al., 2019).
- 2022 FMEA of diversion vulnerabilities in inpatient pharmacies (De Vries et al., 2022).
- 2023 Narcotic drug management processes in a Turkish university hospital (Taser et al., 2023).
3. Definitions and conceptual schema
| Source | Year | Discipline | Definition (paraphrased) | Emphasised dimension |
|---|---|---|---|---|
| Sağlık Bakanlığı, 2020 | 2020 | Accreditation standard | Locked storage, recorded handover with signatures, reports for damaged items and recorded destruction. | Custody and records |
| Fan et al., 2019 | 2019 | Hospital medicine | Diversion as loss or theft of controlled drugs from the hospital, with system-level contributors and safeguards. | Diversion |
| De Vries et al., 2022 | 2022 | Patient safety | Vulnerabilities for diversion within handling, data entry and verification tasks of the medication-use process. | Process vulnerability |
| Dolan et al., 2019 | 2019 | Clinical informatics | Documentation discrepancies as legally relevant mismatches in controlled substance records. | Documentation |
| Sharek et al., 2008 | 2008 | Paediatrics | Narcotic-related adverse drug events as the most common ADEs in hospitalised children. | Clinical harm |
controlled medicines are kept, handed over, used and destroyed under complete, verifiable records that protect both patients and staff
The definitions combine two different risks: clinical harm to patients (Sharek et al., 2008) and loss to illegitimate use (Fan et al., 2019). SKS addresses both through custody records (Sağlık Bakanlığı, 2020).
4. Distinguishing it from neighbouring concepts
Controlled drugs overlap most with high-alert medicines, prescribing and administration (Figure 4): opioids are both high-alert and controlled, and most harm arises at ordering and bedside use. Smaller overlaps with storage and waste reflect cabinet storage and documented disposal.
| Neighbouring concept | How it differs |
|---|---|
| High-alert medications (SİY10) | Opioids are both; high-alert status concerns harm in error (Sağlık Bakanlığı, 2020). |
| Storage (SİY04) | Locked storage is a storage rule with legal force (Zheng et al., 2021). |
| Returns and waste (SİY13, SİY15) | Controlled drug waste must be documented and carries costs and diversion risk (Hertig et al., 2021). |
5. Types and classifications
Diversion contributors are grouped by step: procurement, storage, prescribing, dispensing, administration and waste (Fan et al., 2019). Documentation errors arise especially at intraoperative handoffs between anaesthesia providers (Epstein et al., 2017).
6. Theoretical frameworks and models
Healthcare failure mode and effect analysis structures diversion risk assessment (De Vries et al., 2022); Lean Six Sigma (Creed et al., 2019) and theory of change with visual analytics (Dolan et al., 2019) structure improvement projects.
7. Themes and bibliometric profile
The literature is small (Figure 5). A visual analytics dashboard combined with quality improvement reduced documentation discrepancies in the operating room (Dolan et al., 2019); Lean Six Sigma redesign cut nurse journeys to pharmacy for controlled drug collection by 44% (Creed et al., 2019). Narcotic prescriptions written by trainees at discharge were error-prone, nearly 3% with potential for significant harm (Lee et al., 2009).
Records per year 2026 (incomplete)
Most frequent journals
Most frequent countries
Most frequent author keywords: patient safety (12), medication errors (8), medication management (6), psychotropic drugs (4), quality improvement (4), pediatrics (4), medication safety (4), diversion (4), pharmacy (4), adverse drug events (4). Six records have no address information.
8. The situation in Türkiye
One record has Turkish authors: a description of narcotic drug management processes in a university hospital, emphasising patient and employee safety and prevention of uncontrolled circulation (Taser et al., 2023).
9. Debates and contradictions in the literature
Individual or system accountability? The scoping review argues that system-based strategies broaden the response to diversion beyond individual accountability (Fan et al., 2019).
Does technology close the gaps? Cabinets, bar codes and closed-loop systems help, but processes must supplement their capabilities (Zheng et al., 2021).
Safety or efficiency? Legal procedures consume nursing time; redesign can preserve control while releasing time (Creed et al., 2019).
10. Measurement problems
Diversion is hidden by nature; studies rely on discrepancy counts and audits (Dolan et al., 2019). Narcotic-related harm was tracked with standardised measures across sites in a collaborative (Sharek et al., 2008). Few studies quantify diversion incidence.
11. Research gaps and agenda
- How often does diversion occur in Turkish hospitals, and how is it detected? (Taser et al., 2023)
- Which safeguards prevent diversion at the waste step? (Fan et al., 2019)
- How can handoffs reduce controlled drug documentation errors? (Epstein et al., 2017)
- Can analytics detect diversion patterns early? (Dolan et al., 2019)
- How should SKS handover records be digitised?
12. Implications for practice today
Combine SKS custody rules with analytics: monitor discrepancies on a dashboard (Dolan et al., 2019), assess vulnerabilities with FMEA (De Vries et al., 2022), standardise intraoperative handoffs (Epstein et al., 2017) and use feedback for prescribers (Sullivan et al., 2013).
Summary
- Controlled drugs carry risks of clinical harm and diversion.
- SKS SİY11 requires locked storage and signed handover records.
- Diversion is a system problem with safeguards at every step.
- Documentation discrepancies respond to quality improvement.
- Turkish evidence is limited to a process description.
Discussion questions
- Why are handover signatures important for both patients and staff?
- List diversion vulnerabilities at each step of the medication-use process.
- How could a dashboard reveal diversion?
- Design a waste witnessing procedure for an operating theatre.
- How would you balance legal control and nursing workload?
Further reading
- (Fan et al., 2019): a comprehensive review of diversion.
- (De Vries et al., 2022): diversion vulnerabilities analysed with FMEA.
- (Sharek et al., 2008): reducing narcotic ADEs in children.
- (Dolan et al., 2019): analytics for documentation discrepancies.
- (Creed et al., 2019): Lean redesign of controlled drug processes.
Glossary
| Turkish | English | Short definition |
|---|---|---|
| Kontrole tabi ilaç | Controlled substance | Drug under legal control |
| İlaç saptırma | Drug diversion | Transfer to illegitimate use |
| Devir teslim | Handover (chain of custody) | Documented transfer between staff |
| Kayıt uyumsuzluğu | Documentation discrepancy | Mismatch in controlled drug records |
References
Creed, M., McGuirk, M., Buckley, R., De Brún, A., & Kilduff, M. (2019). Using Lean Six Sigma to Improve Controlled Drug Processes and Release Nursing Time. Journal of Nursing Care Quality, 34(3), 236-241. https://doi.org/10.1097/NCQ.0000000000000364
De Vries, M., Fan, M., Tscheng, D., Hamilton, M., & Trbovich, P. (2022). Vulnerabilities for Drug Diversion in the Handling, Data Entry, and Verification Tasks of 2 Inpatient Hospital Pharmacies: Clinical Observations and Healthcare Failure Mode and Effect Analysis. Journal of Patient Safety, 18(1), E227-E235. https://doi.org/10.1097/PTS.0000000000000744
Dolan, J. E., Lonsdale, H., Ahumada, L. M., Patel, A., Samuel, J., Jalali, A., Peck, J., Derosa, J. C., Rehman, M., Varughese, A. M., & Fernandez, A. M. (2019). Quality Initiative Using Theory of Change and Visual Analytics to Improve Controlled Substance Documentation Discrepancies in the Operating Room. Applied Clinical Informatics, 10(3), 543-551. https://doi.org/10.1055/s-0039-1693688
Epstein, R. H., Dexter, F., Gratch, D. M., & Lubarsky, D. A. (2017). Intraoperative Handoffs Among Anesthesia Providers Increase the Incidence of Documentation Errors for Controlled Drugs. Joint Commission Journal on Quality and Patient Safety, 43(8), 396-402. https://doi.org/10.1016/j.jcjq.2017.02.010
Fan, M., Tscheng, D., Hamilton, M., Hyland, B., Reding, R., & Trbovich, P. (2019). Diversion of Controlled Drugs in Hospitals: A Scoping Review of Contributors and Safeguards. Journal of Hospital Medicine, 14(7), 419-428. https://doi.org/10.12788/jhm.3228
Hertig, J., Jarrell, K., Arora, P., Nwabueze, J., Moureaud, C., Degnan, D. D., & Trujillo, T. (2021). A Continuous Observation Workflow Time Study to Assess Intravenous Push Waste. Hospital Pharmacy, 56(5), 584-591. https://doi.org/10.1177/0018578720931754
Lee, B. H., Lehmann, C. U., Jackson, E. V., Kost-Byerly, S., Rothman, S., Kozlowski, L., Miller, M. R., Pronovost, P. J., & Yaster, M. (2009). Assessing Controlled Substance Prescribing Errors in a Pediatric Teaching Hospital: An Analysis of the Safety of Analgesic Prescription Practice in the Transition From the Hospital to Home. Journal of Pain, 10(2), 160-166. https://doi.org/10.1016/j.jpain.2008.08.004
Sağlık Bakanlığı. (2020). Sağlıkta kalite standartları: Hastane (Sürüm 6.1). Sağlık Hizmetleri Genel Müdürlüğü, Sağlıkta Kalite, Akreditasyon ve Çalışan Hakları Dairesi Başkanlığı. https://dosyamerkez.saglik.gov.tr/Eklenti/41258/0/skshastane-seti-s-61–09082021pdf.pdf
Sharek, P. J., McClead, R. E., Taketomo, C., Luria, J. W., Takata, G. S., Walti, B., Tanski, M., Nelson, C., Logsdon, T. R., Thurm, C., & Federico, F. (2008). An intervention to decrease narcotic-related adverse drug events in children's hospitals. Pediatrics, 122(4), E861-E866. https://doi.org/10.1542/peds.2008-1011
Sullivan, K. M., Suh, S., Monk, H., & Chuo, J. (2013). Personalised performance feedback reduces narcotic prescription errors in a NICU. BMJ Quality & Safety, 22(3), 256-262. https://doi.org/10.1136/bmjqs-2012-001089
Taser, M., Yüksel, S., Çelik, M., & Sarica, C. (2023). Narcotic Drug Management Processes Practice: University Hospital Example. Addicta: The Turkish Journal on Addictions, 10(1), 37-44. https://doi.org/10.5152/ADDICTA.2023.22073
Whipple, J. K., Ausman, R. K., & Quebbeman, E. J. (1992). Narcotic use in the hospital – reasonably safe. Annals of Pharmacotherapy, 26(7-8), 897-901. https://doi.org/10.1177/106002809202600705
Whipple, J. K., Quebbeman, E. J., Lewis, K. S., Gaughan, L. M., Gallup, E. L., & Ausman, R. K. (1994). Identification of patient-controlled analgesia overdoses in hospitalized-patients – a computerized method of monitoring adverse events. Annals of Pharmacotherapy, 28(5), 655-658. https://doi.org/10.1177/106002809402800517
Zheng, W. Y., Lichtner, V., Van Dort, B. A., & Baysari, M. T. (2021). The impact of introducing automated dispensing cabinets, barcode medication administration, and closed-loop electronic medication management systems on work processes and safety of controlled medications in hospitals: A systematic review. Research in Social & Administrative Pharmacy, 17(5), 832-841. https://doi.org/10.1016/j.sapharm.2020.08.001
Source verification and AI use statement
Source verification. All 14 references were generated programmatically from the Web of Science records of the corpus, so authors, year, title, journal and DOI match the records exactly; every in-text citation was cross-checked by code against the reference list. Claims were checked against the record abstracts; full texts were not read. The SKS Hospital Set (Version 6.1) is the only source outside the corpus; it was accessed and read for this chapter.
AI use statement. Claude (Anthropic) was used to merge and de-duplicate the Web of Science exports, assign records to sub-topics, compute the bibliometric indicators and figures, and draft the text under the author’s instructions. The author is responsible for the final content.
Data and supplementary material
Supplementary file S1 (Excel) lists the 115 records of this chapter (authors, year, title, journal, DOI, title match flag), together with the full screening log of the 4948-record corpus and the citation verification report. The list is not reproduced here; it is available from the author on request.
← Chapter 11: High-Alert and Look-Alike Sound-Alike MedicationsChapter 13: Patients’ Own Medicines and Medication Reconciliation →